Company Analysis Sisram Medical Ltd
1. Summary
Advantages
- Dividends (9.91%) are higher than the sector average (5.7%).
- The stock's return over the last year (-26.15%) is higher than the sector average (-49.91%).
- The company's current efficiency (ROE=7.13%) is higher than the sector average (ROE=5.19%)
Disadvantages
- Price (3.4 HK$) is higher than fair price (0.5534 HK$)
- Current debt level 6.73% has increased over 5 years from 0.7147%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Sisram Medical Ltd | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.5% | 2.1% | 2.6% |
| 90 days | -18.5% | -49.9% | -3.5% |
| 1 year | -26.1% | -49.9% | 32.2% |
1696 vs Sector: Sisram Medical Ltd has outperformed the "Healthcare" sector by 23.76% over the past year.
1696 vs Market: Sisram Medical Ltd has significantly underperformed the market by -58.35% over the past year.
Stable price: 1696 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 1696 with weekly volatility of -0.5028% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (3.4 HK$) is higher than the fair price (0.5534 HK$).
Price is higher than fair: The current price (3.4 HK$) is 83.7% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (9.1) is lower than that of the sector as a whole (35.42).
P/E vs Market: The company's P/E (9.1) is lower than that of the market as a whole (26.68).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.6103) is lower than that of the sector as a whole (3.68).
P/BV vs Market: The company's P/BV (0.6103) is higher than that of the market as a whole (-11.94).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.7976) is lower than that of the sector as a whole (7.59).
P/S vs Market: The company's P/S indicator (0.7976) is lower than that of the market as a whole (2.77).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (56.68) is higher than that of the sector as a whole (2.91).
EV/Ebitda vs Market: The company's EV/Ebitda (56.68) is higher than that of the market as a whole (9.94).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 27.21% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (27.21%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (50.73%).
5.4. ROE
ROE vs Sector: The company's ROE (7.13%) is higher than that of the sector as a whole (5.19%).
ROE vs Market: The company's ROE (7.13%) is higher than that of the market as a whole (6.3%).
5.5. ROA
ROA vs Sector: The company's ROA (5.39%) is higher than that of the sector as a whole (3.47%).
ROA vs Market: The company's ROA (5.39%) is higher than that of the market as a whole (3.39%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 9.91% is higher than the average for the sector '5.7%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 9.91% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 9.91% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (33.37%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
